Filter by: patients
Home > Community Treatment Reports and Side Effects > ezetimibe Treatment Report
What is ezetimibe?

Ezetimibe, an anti-lipid agent used with dietary therapy for the treatment of primary hypercholesterolemia (high cholesterol) and sitosterolemia, a rare disorder. In combination with other agents it is used for familial hypercholesterolemia and hyperlipidemia.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
High Cholesterol 39 12 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Other 15 3 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Increased lipids in blood (hyperlipidemia) 11 3 Efficacy_major Efficacy_moderate Efficacy_cant_tell
General health 5 1 Efficacy_slight
choesterol 3 0
Hypercholesterolemia 3 0

See all 80 patients currently taking ezetimibe

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 2
Mild
 0
None
 17

Commonly reported side effects, conditions, and hospitalizations associated with ezetimibe

Weakness in legs 1
Elevated blood pressure 1
Eye Twitching 1
Muscle and joint pain 1

Reported Dosages

  5 mg daily 10 mg daily
  1 Number of Patients: 1 81 Number of Patients: 81  

Reported Stop Reasons

Why Patients Stopped Taking ezetimibe (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 6   Doctor's advice: 40%
Side effects too severe 4   Side effects too severe: 27%
Expense 3   Expense: 20%
Other 2   Other: 13%
Course of treatment ended 2   Course of treatment ended: 13%
Did not seem to work 1   Did not seem to work: 7%

See all 15 patients who’ve stopped taking ezetimibe

Reported Duration See details about how long patients take this treatment ▼

Currently Taking ezetimibe

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking ezetimibe

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of ezetimibe

Always
 19 90%
Usually
 2 10%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of ezetimibe

Very
 0 0%
Somewhat
 0 0%
A little
 3 14%
Not at all
 18 86%

Cost

Paid out of pocket

Cost of ezetimibe

$200+
 0 0%
$100-199
 0 0%
$50-99
 4 25%
$25-49
 7 44%
< $25
 5 31%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.